• Metabiomics is developing a non-invasive diagnostic test for colon polyps and colorectal cancer based on biomarkers of the human microbiome
  • Microbial DNA sequencing using next generation Multi-Tag sequencing techniques
  • Link between bacterial dysbiosis and inflammation associated w...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email Thank you!

Related Research


Company Profile | June 17, 2021

Molzym was founded by Michael Lorenz in 2003 and was acquired by Gradian Diagnostics in December 2019 The company's core technology is a culture‑free enrichment method for bacterial and fungal DNA, which it sells as a kit or different components of the kit as needed by the end user It also ... Not part of subscription

China approves OrgiMed's NGS-based genomic alteration tumor test

News Commentary | September 08, 2021

The test, which was made in collaboration with Bayer, was developed to detect rare NTRK gene fusions in both children and adults. It is a companion diagnostic to a gene inhibitor therapy that specifically targets NTRK cancers. Clients should note how genomic sequencing can be utilized for diagnostic... Not part of subscription


Company Profile | May 13, 2022

​​​​​Develops a rapid pathogen detection platform,TrueRapid; the system works by selectively capturing only live pathogenic bacteria cells by binding to aptamers Claims the system is capable of delivering quantitative analysis for the presence of food pathogens in 20 minutes and reducing the ... Not part of subscription